Biohaven Ltd.
13.88USD
-0.8100 (-5.51%)
Fetching financial statements from SEC filings…
Not enough data yet
A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.
Sign in to share your take on BHVN.
| In $M except per-share | Q2 FY26 | Q1 FY26 | Q4 FY25* | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q4 FY24* | Q3 FY24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| Operating Income | -125 | -130 | -143 | -169 | -212 | -222 | -190 | -178 |
| Net Income | -137 | -131 | -146 | -173 | -198 | -222 | -187 | -160 |
| EPS (Diluted) | -$0.91 | -$0.88 | -$1.12 | -$1.64 | -$1.94 | -$2.17 | -$1.78 | -$1.70 |
* Derived period (computed from FY minus reported quarters). Source: SEC filings (EDGAR)